Stryker Corporation (SYK) Market Performance Summary - April 14, 2026
Current Stock Data
- Ticker: SYK
- Opening Price: $341.00
- Previous Close: $347.17
- Current Price: $351.60
- Price Change: +$4.42 (+1.27%)
- Day's Range: $346.52 - $351.98
- Volume: 68,972 shares traded
- Average Volume: 2,081,268 shares
- Market Capitalization: $134.655 billion
- 52 Week Range: $319.32 - $404.87
Price Movements and Trading Activity
On April 14, 2026, Stryker Corporation's stock experienced a notable increase, closing at $351.60, which represents a gain of 1.27% from the previous day's close of $347.17. The stock opened at $341.00 and fluctuated within a range of $346.52 to $351.98 throughout the trading session. The trading volume of 68,972 shares was significantly lower than the average volume of 2,081,268 shares, indicating a quieter trading day.
Key Events and News
- Acquisition of Amplitude Vascular Systems: Stryker announced its intention to acquire Amplitude Vascular Systems, a company specializing in intravascular lithotripsy technology. This acquisition is expected to bolster Stryker's vascular care portfolio and enhance its competitive position in the medical technology market.
- Recovery from Cyberattack: The company is in the process of recovering from a cyberattack that had previously disrupted its operations. Despite the challenges posed by this incident, Stryker has reaffirmed its full-year guidance for growth and earnings, showcasing resilience in its operational capabilities. Reports indicate that Stryker is now fully operational post-cyberattack, which may positively influence investor sentiment.
Analyst Insights
Analysts maintain a generally positive outlook on Stryker Corporation. The average target price for the stock is estimated at $420.62, with a high target of $469.00 and a low of $316.00. Recent ratings from analysts include "Buy" recommendations, indicating confidence in Stryker's future performance. For instance, BTIG reiterated a "Buy" rating on April 14, 2026, with a maintained price target of $397.
Financial Performance
- PE Ratio (TTM): 41.86
- EPS (TTM): $8.40
- Forward Dividend & Yield: $3.52 (1.01%)
- Ex-Dividend Date: March 31, 2026
Historical Performance
- Year-To-Date (YTD) Performance: 0.04%
- 1-Year Performance: -0.52%
- 5-Year Performance: 39.36%
Company Overview
Stryker Corporation is a leading medical technology company, founded in 1941 and headquartered in Portage, Michigan. The company operates in two main segments: MedSurg and Neurotechnology, which offers a range of surgical equipment and technologies aimed at patient safety and care, and Orthopaedics, focusing on joint replacements and trauma surgeries, including robotics applications in surgery. Stryker employs approximately 56,000 full-time employees and distributes its products in around 61 countries.
Conclusion
In summary, Stryker Corporation's stock has shown positive movement today, reflecting a strategic focus on growth through acquisitions and a robust recovery from operational disruptions. The company's resilience, coupled with favorable analyst ratings and solid financial fundamentals, positions Stryker well within the medical technology sector. The ongoing developments and market performance will be closely monitored by investors as the company continues to navigate its operational landscape.
Explore more exclusive insights at nextfin.ai.
